Clinical Research Directory
Browse clinical research sites, groups, and studies.
2 clinical studies listed.
Filters:
Tundra lists 2 Stage II-III Gastric Cancer clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT06157216
Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer
This is a multicenter, single-arm, interventional study to explore the feasibility of circulating tumor DNA (ctDNA)-MRD testing to guide postoperative adjuvant treatment strategies in patients with stage II-III gastric cancer.
Gender: All
Ages: 18 Years - 75 Years
Updated: 2025-01-07
1 state
NCT06609759
Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer
For patients with stage II-III gastric cancer after radical D2 resection and R0 resection, postoperative adjuvant therapy guided by ctDNA-MRD (MRD-GATE external cohort) was not inferior to the standard chemotherapy regimen (this cohort).
Gender: All
Ages: 18 Years - 75 Years
Updated: 2024-09-24
1 state